FIELD: medicine.
SUBSTANCE: declared group of inventions refers to medicine and pharmaceutics and represents application of composition containing more than 90 wt. % norbixin, obtained by way of purification from Bixa orellana seed extract, for photoprotection of cells of retinal pigment epithelium (RPE) in mammals by administering to said mammal said composition in amount of 0.48 mg/kg of body weight to 48 mg/kg of body weight per day, and a composition containing more than 95 wt. % norbixin, obtained by purifying from a Bixa orellana extract, for use in photoprotection of cells of retinal pigment epithelium (RPE) in mammals.
EFFECT: declared group of inventions is highly effective for photoprotection of cells of retinal pigment epithelium (RPE) in mammals.
16 cl, 13 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CHEMICAL COMPOUNDS ACTING ON EYES, AND THEIR USE IN TREATING EYE DISEASES | 2020 |
|
RU2830634C1 |
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
| DEMETHYLATION FOR TREATMENT OF EYE DISEASE | 2019 |
|
RU2804300C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF DRUSEN IN AGE-RELATED MACULAR DYSTROPHY | 2020 |
|
RU2750907C1 |
| BDNF-BASED (BRAIN-DERIVED NEUROTROPHIC FACTOR) OPHTHALMIC PREPARATIONS AND USING THEM | 2010 |
|
RU2564920C2 |
| METHOD OF STEM CELL TRANSPLANTATION IN RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2018 |
|
RU2707264C1 |
| VECTOR, METHOD FOR TREATING CHOROIDITIS, METHOD FOR SELECTIVE EXPRESSION OF POLYNUCLEOTIDE | 2014 |
|
RU2723101C2 |
| USE OF THE COMPOUND OF FORMULA I, A PHARMACEUTICAL COMPOSITION, A MEDICINAL AGENT | 2016 |
|
RU2730854C2 |
| GENE THERAPY | 2016 |
|
RU2740038C2 |
| METHOD OF TREATING "DRY" FORM OF AGE MACULAR DEGENERATION | 2008 |
|
RU2375016C1 |
